United States  


Latest news and video coverage curated from trusted media outlets

FDA Calls for Zantac to Be Pulled From Market [Video]

FDA Calls for Zantac to Be Pulled From Market

The FDA is instructing that all prescription and over-the-counter ranitidine drugs, known by brand name Zantac, are pulled from the market immediately.

Credit: Cover Video     Duration: 01:00Published
Baptist plasma [Video]

Baptist plasma

Test treatment partnership

Credit: WTVQ Lexington, KYPublished

Health Headlines - 4/1/20 [Video]

Health Headlines - 4/1/20

In today's health headlines we talk about how a group of doctors in Michigan have come up with a way to sterilize personal protective equipment so that they can be used more than once. Also, the FDA is..

Credit: FOX 47 News Michigan     Duration: 02:12Published
FDA Calls On Manufactures To Pull Zantac [Video]

FDA Calls On Manufactures To Pull Zantac

FDA is calling on manufactures to pull Zantac from the market immediately due to contamination.

Credit: KDKA CBS 2 Pittsburgh     Duration: 00:26Published
FDA Calls For Heartburn Drug Zantac To Be Pulled Off The Market [Video]

FDA Calls For Heartburn Drug Zantac To Be Pulled Off The Market

The US Food and Drug Administration has requested that manufacturers pull all prescription and over-the-counter Zantac from the market immediately, the agency announced on Wednesday. Katie Johnston..

Credit: CBS4 Miami     Duration: 00:25Published

You Might Like

FDA finds cancer-causing chemical in heartburn medicine Zantac

Small amounts of a cancer-causing chemical have been found in the popular heartburn medication Zantac, as well is in generic forms of the drug, known as Ranitidine. The FDA is not issuing a recall and..
CBS News - Published

Novartis halts distribution of generic heartburn medication

The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in Zantac and related heartburn medications. Dr. Jon..
CBS News - Published

Chemical found in Zantac raises concerns

The FDA recently warned about a potentially dangerous impurity in the popular heartburn drug Zantac. The nation's three largest pharmacy chains reacted by pulling it from store shelves. Dr. Jon LaPook..
CBS News - Published

Zantac and its generic version found with chemical that could lead to cancer

There are increasing concerns about the popular heartburn drug Zantac and its generic version because of a chemical that could lead to cancer. Three large pharmacy chains in the U.S. recently pulled..
CBS News - Published

Lab investigates heartburn drug’s possible cancer link

The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the FDA. A lab in California..
CBS News - Published Also reported by •CBS 2

Melville man files lawsuit against Zantac manufacturers

A Melville man who says he developed a rare bladder cancer after regularly ingesting Zantac has filed a federal lawsuit against the drug's manufacturers.
Newsday - Published

FDA Says Zantac Should Be Pulled From Market, Citing Cancer Risk

Major pharmacies had already pulled the popular heartburn drug and its generic equivalents due to a contaminant. Now the Food and Drug Administration says definitively they should not be sold or used.
NPR - Published

FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Chicago S-T - Published

Zantac products should not be sold or used, FDA warns, citing cancer danger

The Food and Drug Administration on Wednesday asked companies to stop selling all forms of the heartburn drug Zantac, after concluding that a potential cancer-causing contaminant can build up in the..
Seattle Times - Published Also reported by •NYTimes.com

FDA Asks for Recalls of Sanofi's Zantac and All Generic Versions

The agency says there is a risk that some of the heartburn pills may contain unacceptable levels of NDMA, a possible carcinogen.
Motley Fool - Published

FDA wants heartburn meds off the market due to contamination

WASHINGTON (AP) — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications..
SeattlePI.com - Published

FDA Calls For Heartburn Drug Zantac To Be Pulled Off Market Immediately

The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately, the agency..
cbs4.com - Published

Lab finds new clues in Zantac's possible cancer link

Last fall the FDA said they had detected a "probable" cancer-causing chemical in the generic form of Zantac.
CBS News - Published

'It's a much more serious issue': Researchers study Zantac cancer risk as FDA probes cause

Zantac and its generics are routinely used by millions of heartburn sufferers and available with or without a prescription. How did the drug become a cancer risk? Early studies show potential signs.
USATODAY.com - Published

Walgreens Boots considers going private: media reports

Walgreens Boots Alliance Inc (NASDAQ:WBA) shares were higher in pre-market trading after Reuters reported the group is considering going private. The company, which has a market value of over US$55bn,..
Proactive Investors - Published

GlaxoSmithKline shares close to 17-year highs as it upgrades full-year earnings forecasts

GlaxoSmithKline PLC’s (LON:GSK) shares headed to their highest levels in 17 years on Wednesday after the drugmaker upgraded its full-year earnings forecasts following solid third-quarter sales. The..
Proactive Investors - Published

U.S. FDA says carcinogen not found in alternatives of Zantac and its generics

U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found..
Reuters - Published

Over-the-counter heartburn drug Zantac pulled in U.S., Canada

Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.
Newsday - Published Also reported by •SeattlePI.comSeattle Times

Heartburn Drug Zantac Pulled From Store Shelves Amid Cancer Concerns

A popular heartburn drug is being pulled from store shelves amid growing concerns it could cause cancer.
CBS 2 - Published

Sanofi becomes latest drugmaker to recall Zantac

Recall comes after federal regulators found unsafe levels of a known carcinogen in the popular heartburn drug
CBS News - Published

 Page 1  〉